Xencor reported $846.27M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Amgen AMGN:US USD 65.12B 1.42B
Arrowhead Research ARWR:US USD 891.49M 199.55M
AstraZeneca AZN:LN USD 96.48B 2.3B
Biogen BIIB:US USD 24.55B 300.1M
Cytokinetics CYTK:US USD 1.01B 61.19M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Karyopharm Therapeutics KPTI:US USD 358.17M 126.94M
Macrogenics MGNX:US USD 280.47M 85.12M
Novartis NOVN:VX USD 117.45B 1.01B
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Seattle Genetics SGEN:US USD 3.67B 55.45M
Xencor XNCR:US USD 846.27M 11M